SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-000194
Filing Date
2023-01-11
Accepted
2023-01-11 08:00:19
Documents
14
Period of Report
2023-01-11
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20230111x8k.htm   iXBRL 8-K 30682
  Complete submission text file 0001558370-23-000194.txt   244617

Data Files

Seq Description Document Type Size
2 EX-101.SCH tmb-20230111.xsd EX-101.SCH 4051
3 EX-101.DEF tmb-20230111_def.xml EX-101.DEF 3493
4 EX-101.LAB tmb-20230111_lab.xml EX-101.LAB 634
5 EX-101.PRE tmb-20230111_pre.xml EX-101.PRE 10409
8 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20230111x8k_htm.xml XML 4841
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14778 | Film No.: 23522565
SIC: 2834 Pharmaceutical Preparations